Phuong Khanh Morrow

Insider Reports History

Entity
Individual
Location
C/O Crispr Therapeutics, 610 Main Street, Cambridge, MA
Signature
/s/ Elizabeth Ryland Waldinger, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Phuong Khanh Morrow:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CRISPR Therapeutics AG Chief Medical Officer Common Shares 4.41K $276K $62.50 May 24, 2023 Direct
CRISPR Therapeutics AG Chief Medical Officer Restricted Stock Units 20.8K May 23, 2023 Direct
CRISPR Therapeutics AG Chief Medical Officer Stock Option (Right to Buy) 16.7K Oct 13, 2023 Direct

Insider Reports Filed by Phuong Khanh Morrow

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRSP CRISPR Therapeutics AG Oct 13, 2023 1 $0 4 Oct 17, 2023 Chief Medical Officer
CRSP CRISPR Therapeutics AG May 23, 2023 3 -$167K 4 May 25, 2023 Chief Medical Officer
CRSP CRISPR Therapeutics AG Mar 10, 2023 2 $0 4 Mar 14, 2023 Chief Medical Officer
CRSP CRISPR Therapeutics AG Oct 7, 2022 1 $0 4 Oct 12, 2022 Chief Medical Officer
CRSP CRISPR Therapeutics AG May 23, 2022 2 $0 4 May 24, 2022 Chief Medical Officer
CRSP CRISPR Therapeutics AG May 23, 2022 0 $0 3 May 23, 2022 Chief Medical Officer